News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 181–216
- Matches
- 679
- Sources here
- 17
- Companies here
- 9
Active search
679 matching headlines
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Allegiant Travel Co (ALGT) (Q2 2026) Earnings Call Highlights: Record Revenue and Strategic Integration Drive Strong Performance
Allegiant Travel Co (ALGT) reported record standalone revenue and an industry-leading operating margin for Q2 2026, with the Sun Country integration progressing well. The company posted a combined revenue of $943.5 million and a consolidated EPS of $2.19, leading to a full-year EPS outlook …
Earnings call transcript: Travere Therapeutics jumps on q2 2026 sales beat
Travere Therapeutics reported Q2 2026 revenue of $169.6 million, exceeding analyst forecasts, driven by strong sales of its kidney drug FILSPARI. The drug's sales rose 96% year-over-year to $141.1 million, benefiting from accelerated demand in both IgA nephropathy and the newly launched FSGS indication. …
Press Release: Travel + Leisure Co. Declares Cash Dividend
Travel + Leisure Co. announced that its Board of Directors declared a quarterly cash dividend of $0.45 per share on the company's common stock. The dividend is payable on September 13, 2024, to shareholders of record as of August 29, 2024.
American Express Global Business Travel posts Q2 2026 revenue $870M, adjusted EBITDA $178M
American Express Global Business Travel (GBTG) reported strong Q2 2026 results, with revenue up 38% year-over-year to $870 million and adjusted EBITDA reaching $178 million. The company highlighted significant business momentum, including $3.5 billion in new wins, a 95% customer retention rate, and advancements …
Travere signals potential for more than $3B in peak annual FILSPARI sales as FSGS launch exceeds expectations
Earnings Call Insights: Travere Therapeutics (TVTX) Q2 2026 MANAGEMENT VIEW * "The second quarter was exceptional." (President, CEO & Director Eric Dube) "This was the first quarter with FILSPARI commercially available across both IgA nephropathy and FSGS, and we are very pleased with the …
Travere Therapeutics Q2 Swings to Adjusted Loss, Revenue Rises
Travere Therapeutics reported an adjusted loss in Q2 compared to a profit last year, despite an increase in revenue. The company's adjusted net loss was $0.34 per share, while total revenue grew to $65.4 million from $51.7 million in the prior year quarter. The …
Travel + Leisure Co. Named to Business Insider’s America’s High-Growth Companies 2026 List
Travel + Leisure Co. has been recognized on Business Insider’s inaugural America’s High-Growth Companies 2026 list. This recognition highlights the company's sustained growth, financial strength, and long-term stability, achieved through its multi-brand strategy and commitment to expanding global reach and delivering exceptional vacation experiences. …
Earnings call transcript: Allegiant Travel posts Q2 2026 profit beat, shares slip
Allegiant Travel Co. reported record Q2 2026 earnings of $2.19 per share, significantly beating analyst expectations for a loss, although revenue of $943.5 million fell short of forecasts. The airline highlighted strong leisure demand, higher yields, and robust ancillary revenue, achieving a 9.2% operating …
Travere (TVTX) Reports Q2 Earnings: What Key Metrics Have to Say
For the quarter ended June 2026, Travere Therapeutics (TVTX) reported revenue of $169.58 million, up 48.2% over the same period last year. EPS came in at -$0.37, compared to -$0.14 in the year-ago quarter. The reported revenue represents a surprise of +10.16% over the …
Earnings Flash (ALGT) Allegiant Travel Company Posts Q2 Adjusted EPS $2.19 per Share, vs. FactSet Est of $1.11
Allegiant Travel Company (ALGT) reported strong Q2 adjusted EPS of $2.19 per share, significantly surpassing FactSet's estimate of $1.11. The company's stock, ALGT, showed a 1.56% increase in its 5-day change and a 23.24% increase year-to-date. Allegiant Travel is a leisure travel company focusing …
Travel + Leisure Sets Sept. 30 Payment for $0.60 Dividend
Travel + Leisure Co. (NYSE: TNL) has announced a regular cash dividend of $0.60 per share. This dividend is payable on September 30, 2026, to shareholders who are on record as of September 16, 2026. The company, a leading leisure travel provider, offers diverse …
Atlanta Braves Holdings earnings on deck: BravesVision test looms By Investing.com
Atlanta Braves Holdings (BATRA) is set to announce its second-quarter earnings, with analysts projecting a significant sequential revenue jump but a year-over-year decline. The primary focus for investors will be the performance of the newly launched BravesVision broadcasting platform and its ability to offset …
Allegiant earnings on deck: Can Sun Country deal deliver growth? By Investing.com
Allegiant Travel Company is reporting second-quarter earnings, the first since its $1.5 billion acquisition of Sun Country Airlines. Analysts are keen to see if the deal can deliver growth, with expectations of a significant revenue jump and positive analyst sentiment reflecting anticipated synergies and …
GBTG Stock Price and Chart — NYSE:GBTG
This article provides a detailed overview of Global Business Travel Group, Inc. (GBTG) stock, including its current price, market capitalization, financial performance, and analyst ratings. It also lists ETFs holding the stock and answers frequently asked questions regarding GBTG's financials, future outlook, and stock …
Earnings Flash (TVTX) Travere Therapeutics, Inc. Reports Q2 Revenue $169.6M, vs. FactSet Est of $157.3M
Travere Therapeutics, Inc. (TVTX) announced its Q2 revenue of $169.6 million, exceeding FactSet's estimate of $157.3 million. This financial update indicates a stronger-than-anticipated performance for the biopharmaceutical company during the second quarter of 2026. The company specializes in therapies for rare kidney and metabolic …
More than 3,000 companies evaluated before Travel + Leisure made list
Travel + Leisure Co. (NYSE: TNL) has been named to Business Insider's America’s High-Growth Companies 2026 list, recognizing its sustained growth, financial strength, and long-term stability. Over 3,000 eligible U.S. public companies were evaluated for this inaugural list based on 11 financial metrics across …
Global Business Travel Group, Inc. Q2 Sales Increase
(RTTNews) - Global Business Travel Group, Inc. (GBTG) reported earnings for second quarter of $15 million The company's bottom line totaled $15 million, or $0.03 per share. This compares with $13 million, or $0.03 per share, last year. The company's revenue for the period …
American Express Global Business Travel Reports Strong Q2 2026 Financial Results
NEW YORK, August 04, 2026--(BUSINESS WIRE)--American Express Global Business Travel, which is operated by Global Business Travel Group, Inc. (NYSE: GBTG) ("Amex GBT" or the "Company"), a leading software and services company for travel, expense and meetings & events, today reported second quarter 2026 …